drugset / Trial / NCT05932511

Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

NCT05932511

Phase 0 Unknown 15 enrolled Center for Biomedical Research, Inc.
NaSingle-groupOpen-labelTreatment

Summary

Randomized comparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment of biopsy proven squamous cell carcinomas of the skin in otherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

Timeline

Start
2023-06-12
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 30 % Topical